Fig. 12
From: Protein degradation technology: a strategic paradigm shift in drug discovery
a Structure of LYTAC, antibody-conjugated glycopeptide ligand. b The mechanism of LYTAC-induced degradation of intracellular proteins and membrane-associated proteins. c Antibody-tri-GalNAc conjugate (GalNAc-LYTAC)